The next board meeting for Arcutis Biotherapeutics Inc is on 10 Sep 2025 for the purpose of HC Wainwright 27th Annual Global Investment ConferenceSee details
Arcutis Biotherapeutics Inc has a share price target of US$ 22, revenue growth forecast of 69.1%, and profit growth estimate of 58.4% for FY25, based on top 8 analyst calls.